HONG KONG, Dec. 7, 2021
/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO)
("GCBC" or the "Company"), China's
leading provider of cord blood collection, laboratory testing,
hematopoietic stem cell processing, and stem cell storage services,
today announced the results of its 2021 Annual General Meeting of
shareholders, held on December 7,
2021, in Hong Kong S.A.R., China.
At the Annual General Meeting, the Company's
shareholders
- ratified the re-appointment of KPMG Huazhen LLP as independent
auditors of the Company for the financial year ending March 31, 2022, and authorized any duly formed
committee of the directors to fix the remuneration of the
independent auditors; and
- re-elected Ms. Jennifer J. Weng,
Mr. Ping Xu and Mr. Jacky Cheng as Class C directors of the Company
until the Company's 2024 annual general meeting, or until their
respective successors are duly appointed and qualified.
About Global Cord Blood Corporation
Global Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses. Global
Cord Blood Corporation provides cord blood collection, laboratory
testing, hematopoietic stem cell processing and stem cell storage
services. For more information, please visit the Company's website
at: http://www.globalcordbloodcorp.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, performance and
results of operations, and underlying assumptions and other
statements that are other than statements of historical facts.
These statements are subject to uncertainties and risks including,
but not limited to, product and service demand and acceptance,
changes in technology, economic conditions, the impact of
competition and pricing, government regulation, and other risks
contained in statements filed from time to time with the U.S.
Securities and Exchange Commission. All such forward-looking
statements, whether written or oral, and whether made by or on
behalf of the Company, are expressly qualified by the cautionary
statements and any other cautionary statements which may accompany
the forward-looking statements. In addition, the Company disclaims
any obligation to update any forward-looking statements to reflect
events or circumstances after the date hereof.
View original
content:https://www.prnewswire.com/news-releases/global-cord-blood-corporation-announces-results-of-2021-annual-general-meeting-301439040.html
SOURCE Global Cord Blood Corporation